We are pleased to announce that all 5 patients in the first in human DurAVR™ study have passed the 7-day follow up with an excellent performance status. READ - full update on @paroactive_au article https://bit.ly/32OdrNI #DurAVR #lastslongerworksbetter $AVR #TAVR

WATCH – Expert Interview with Dr C. Meduri from Karolinska University Hospital (Stockholm – SE) where he discusses the “The Science Behind a Valve Designed for Life” – #PCRValves #TAVR #DurAVR #lastslongerworksbetter $AVR https://bit.ly/3rg2caZ

READ - @proactive_au “Anteris Technologies successfully implants five heart patients with valve technology” providing further insights on how the DurAVR™ THV implant procedures for all five patients were successful and proceeded without any complications https://bit.ly/3cErAyK